HEALTHNY POST
Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month — here’s who qualifies
Up to 14 million Medicare patients may qualify for GLP-1 drugs at $50 a month for weight loss. These drugs were previously available for diabetes but are now accessible for weight loss under Medicare.
Related Signal
Adjacent reporting
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- A new Medicare option for weight loss drugs is coming: Here's what to know
- France to partially reimburse weight-loss drugs for obesity patients
- Generic Ozempic is now about $100 a month across the country. Canadians are taking note
- A new Medicare option for weight loss drugs is coming: Here's what to know